JSS Medical Research and Pharm-Olam International Form Strategic Alliance
Montreal, Canada, August 13, 2009 --(PR.com)-- JSS Medical Research, a Canadian headquartered full service CRO is pleased to announce a strategic alliance with Pharm-Olam International, one of the world’s leading clinical research organizations. The alliance will provide Pharm-Olam with the expertise of JSS Medical Research in post-marketing observational, health economics, and outcome studies conducted on behalf of global pharmaceutical, biotech, medical and surgical device, nutraceutical and consumer health companies.
JSS Medical Research will benefit from Pharm-Olam’s global coverage in over 40 countries including the USA, Europe, Russia, Latin America, India, and South Africa with over 500 employees worldwide.
“This is another milestone in the deployment of JSS Medical Research’s international growth strategy, after opening our offices in Ontario and New Jersey in 2008. Working closely with Pharm-Olam enables us to offer our clients a true global service of the highest quality. We are very pleased to enter a new era with this alliance and are looking forward to continue building a strong relationship between the two entities”, says Dr. John S. Sampalis, Professor at McGill University and President and founder of JSS Medical Research.
“With the JSS alliance, Pharm-Olam is even better positioned to serve the growing demand for specialized services like health-outcomes research and expands our operations in Canada", said Matt Delaney, Director of Strategic Development at Pharm-Olam.
About JSS Medical Research
Founded in 1997, JSS Medical Research Inc. is a clinical research organization that manages Phase I to Phase IV trials and specializes in Outcomes Research on behalf of pharmaceutical, biotech and nutraceutical companies. The organization responds to the evolving needs of the stakeholders in the healthcare field for high quality, scientifically rigorous and sound clinical research services.
About Pharm-Olam International
With 25 offices among the world’s most populated cities, Pharm-Olam International provides cost effective coverage for clinical trials in both emerging and traditional markets for all phases of clinical research. Since 1994, Pharm-Olam has focused on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines.
For further information, please contact;
Dr. Wolfgang Renz, General Manager
JSS Medical Research Inc.
1+ (514) 934-6116 ext. 237
###
JSS Medical Research will benefit from Pharm-Olam’s global coverage in over 40 countries including the USA, Europe, Russia, Latin America, India, and South Africa with over 500 employees worldwide.
“This is another milestone in the deployment of JSS Medical Research’s international growth strategy, after opening our offices in Ontario and New Jersey in 2008. Working closely with Pharm-Olam enables us to offer our clients a true global service of the highest quality. We are very pleased to enter a new era with this alliance and are looking forward to continue building a strong relationship between the two entities”, says Dr. John S. Sampalis, Professor at McGill University and President and founder of JSS Medical Research.
“With the JSS alliance, Pharm-Olam is even better positioned to serve the growing demand for specialized services like health-outcomes research and expands our operations in Canada", said Matt Delaney, Director of Strategic Development at Pharm-Olam.
About JSS Medical Research
Founded in 1997, JSS Medical Research Inc. is a clinical research organization that manages Phase I to Phase IV trials and specializes in Outcomes Research on behalf of pharmaceutical, biotech and nutraceutical companies. The organization responds to the evolving needs of the stakeholders in the healthcare field for high quality, scientifically rigorous and sound clinical research services.
About Pharm-Olam International
With 25 offices among the world’s most populated cities, Pharm-Olam International provides cost effective coverage for clinical trials in both emerging and traditional markets for all phases of clinical research. Since 1994, Pharm-Olam has focused on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines.
For further information, please contact;
Dr. Wolfgang Renz, General Manager
JSS Medical Research Inc.
1+ (514) 934-6116 ext. 237
###
Contact
JSS Medical Research Inc.
Kevin Watson
514.934.6116
www.jssresearch.com
Kevin Watson
514.934.6116
www.jssresearch.com
Contact
Categories